News

Weekly Policy Update: CBSA Submits Comment Letter to Senate Finance Committee’s Health Task Force Urging Repeal of the Medical Device Excise Tax

Friday, June 14, 2019

 

CutisPharma Announces Acquisition of Silvergate Pharmaceuticals, Name Change to Azurity Pharmaceuticals

Thursday, June 13, 2019

WOBURN, Mass. (Jun. 12, 2019) – CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Pharmaceuticals.
 

Weekly Policy Update: CBSA Attends the 2019 BIO International Convention

Monday, June 10, 2019

Last week CBSA President and CEO Jennifer Jones Paton and Vice President Emily Roberts attended the 2019 BIO International Convention in Philadelphia. The event brings together over 16,000 attendees from around the world for educational sessions, networking events, and partnering meetings. For the CBSA team, it’s a great opportunity to connect with industry partners, biotechnology companies, and other state associations to discuss collaboration opportunities and share best practices.  

Colorado BioScience Association Celebrates State’s Collaborative Nature

Monday, June 03, 2019

New Magazine Offers In-Depth Financing Data and Insights on Medical Device and Drug Approvals 
Continue Reading